Cite

HARVARD Citation

    Coomans de Brachène, A. et al. (2020). Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta‐cell protection in type 1 diabetes. Diabetes, obesity & metabolism. 22 (10), pp. 1827-1836. [Online]. 
  
Back to record